Samsung Biologics, Active Community... Stock Price Up 6.09%.

At this time, posts about Samsung Biologics are rapidly increasing on portals and stock communities. Today, foreigners have net sold 21,248 shares of Samsung Biologics, and institutions have net sold 2,000 shares, according to preliminary data. Samsung Biologics is known as the holding company for Samsung Group's bio business.

As of 11:30 AM on the 15th, Samsung Biologics' stock price is 854,000 KRW, up 6.09% from the previous day, with a trading volume of 367,168 shares, which is 81.89% of the 5-day average trading volume. On June 12, Samsung Biologics was a market topic for "consecutive record highs... breaking 800,000 KRW."

In addition to Samsung Biologics, posts by investors are also surging for Ilyang Pharmaceutical Preferred (007575), Daehan New Pharm (054670), and Doosan Fuel Cell 1 Preferred (33626K).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.